BeStock  
Stocks › Biotechnology › BRVE

Braveheart Bio BRVE

US equityMarket cap rank #2736Biotechnology
$20.39 +$1.12 (+5.81%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $20.39 0.00%
Open$19.29
Prev close$19.27
Day range$18.83 – $21.16
Volume866.7K
Market cap$1.83B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-26.8x
CheapRich

Near the bottom of its 5-year range · 4th percentile, 5-year average -10.5x

Price / book3.5x
CheapRich

Near the top of its 5-year range · 96th percentile, 5-year average -19.2x

#3978 of 5330 stocks by PB (1 = cheapest)

P/E over five years

-31x-20x-9x2xJul '26Sep '26Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$26.85
Price vs. fair value-24.1%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.54 – -19.23 96% (pricier than usual) #3978 of 5330 (1 = cheapest)
PE -26.77 -16.74 -10.52 4% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on BRVE.

Sign in to join the discussion.

Scroll to Top